Theologidis, Vasileios
Ferreira, Sara A.
Jensen, Nanna M.
Gomes Moreira, Diana
Ahlgreen, Ole A.
Hansen, Mads W.
Rosenberg, Emilie D.
Richner, Mette
Faress, Islam
Gram, Hjalte
Jensen, Poul Henning
Borghammer, Per
Nyengaard, Jens R.
Romero-Ramos, Marina
Vægter, Christian B.
van de Berg, Wilma D. J.
Van Den Berge, Nathalie
Jan, Asad https://orcid.org/0000-0002-3636-0070
Funding for this research was provided by:
Lundbeck Foundation (R383-2022-180)
Lundbeck Foundation (R383-2022-180)
Michael J. Fox Foundation for Parkinson's Research (MJFF-021498)
Article History
Received: 4 October 2024
Accepted: 5 February 2025
First Online: 17 February 2025
Declarations
:
: Post-mortem brain tissue from subjects with clinical parkinsonism and neurologically normal controls were acquired from the Netherlands Brain Bank (NBB; Amsterdam, The Netherlands, ). Donors or their next of kin signed informed consent for brain autopsy, the use of brain tissue and the use of medical records for research purposes. The brain donor program of the NBB and NABCA is approved by the local medical ethics committee of the VUmc, Amsterdam (approva l# NBB 2009.148). For a detailed description of cases and cohorts, see Reference []. Ethical approval for the transgenic M83 mouse colonies (housing, breeding) and the experimental procedures was obtained by the relevant authorities of Denmark (Dyreforsøgstilsynet) approval # 2022–15-0201–01294 issued to CBV, co-author).
: Not applicable. The manuscript does not contain an individual person’s data in any form.
: The authors declare no competing interests.